These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8640763

  • 21. Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.
    Krystal GW, Carlson P, Litz J.
    Cancer Res; 1997 Jun 01; 57(11):2203-8. PubMed ID: 9187122
    [Abstract] [Full Text] [Related]

  • 22. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 01; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 23. Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family.
    Bishop PC, Myers T, Robey R, Fry DW, Liu ET, Blagosklonny MV, Bates SE.
    Oncogene; 2002 Jan 03; 21(1):119-27. PubMed ID: 11791182
    [Abstract] [Full Text] [Related]

  • 24. The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines.
    Soto-Cruz I, Rangel-Corona R, Valle-Mendiola A, Moreno-Morales X, Santiago-Pérez R, Weiss-Steider B, Cáceres-Cortés JR.
    Cancer Invest; 2008 Mar 03; 26(2):136-44. PubMed ID: 18259943
    [Abstract] [Full Text] [Related]

  • 25. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H, Hung W, Tremblay E, Wojcik J, Gui J, Ho J, Klassen J, Campling B, Elliott B.
    J Cell Biochem; 2002 Mar 03; 86(4):665-77. PubMed ID: 12210733
    [Abstract] [Full Text] [Related]

  • 26. [Effects of Her-2/neu siRNA-mediated gene silencing on cell cycle and apoptosis of lung adenocarcinoma cells].
    Ren SH, Wang JW, Zhang L.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 15; 85(22):1530-4. PubMed ID: 16179111
    [Abstract] [Full Text] [Related]

  • 27. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
    Lyu MA, Kurzrock R, Rosenblum MG.
    Biochem Pharmacol; 2008 Feb 15; 75(4):836-46. PubMed ID: 18082672
    [Abstract] [Full Text] [Related]

  • 28. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.
    Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM.
    Cancer Res; 1998 Nov 15; 58(22):5123-9. PubMed ID: 9823322
    [Abstract] [Full Text] [Related]

  • 29. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.
    Mol Cancer Res; 2007 Apr 15; 5(4):393-401. PubMed ID: 17426253
    [Abstract] [Full Text] [Related]

  • 30. Basic science of HER-2/neu: a review.
    Hung MC, Lau YK.
    Semin Oncol; 1999 Aug 15; 26(4 Suppl 12):51-9. PubMed ID: 10482194
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.
    Shi D, He G, Cao S, Pan W, Zhang HZ, Yu D, Hung MC.
    Mol Carcinog; 1992 Aug 15; 5(3):213-8. PubMed ID: 1350198
    [Abstract] [Full Text] [Related]

  • 32. Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin.
    Nguyen DM, Chen A, Mixon A, Schrump DS.
    J Thorac Cardiovasc Surg; 1999 Nov 15; 118(5):908-15. PubMed ID: 10534697
    [Abstract] [Full Text] [Related]

  • 33. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
    Tsai CM, Chang KT, Perng RP, Mitsudomi T, Chen MH, Kadoyama C, Gazdar AF.
    J Natl Cancer Inst; 1993 Jun 02; 85(11):897-901. PubMed ID: 8098377
    [Abstract] [Full Text] [Related]

  • 34. Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines.
    Bando T, Kasahara K, Shibata K, Nakatsumi Y, Fujimura M, Matsuda T.
    Anticancer Res; 1994 Jun 02; 14(6B):2727-30. PubMed ID: 7872708
    [Abstract] [Full Text] [Related]

  • 35. p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.
    Akita K, Inagaki H, Sato S, Niimi T, Maeda H, Ninomiya S, Achiwa H, Kawaguchi H, Yamakawa Y, Fujii Y, Shimizu S, Eimoto T, Ueda R.
    Jpn J Cancer Res; 2002 Sep 02; 93(9):1007-11. PubMed ID: 12359054
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of the quantified expression of p185 in non-small cell lung cancer.
    Cantero R, Torres AJ, Maestro ML, Hernando F, Sanz MT, Del Barco V, Gómez A, Fernández C, Balibrea JL.
    J Thorac Cardiovasc Surg; 2000 Jun 02; 119(6):1119-25. PubMed ID: 10838527
    [Abstract] [Full Text] [Related]

  • 37. p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma.
    Nanni P, Pupa SM, Nicoletti G, De Giovanni C, Landuzzi L, Rossi I, Astolfi A, Ricci C, De Vecchi R, Invernizzi AM, Di Carlo E, Musiani P, Forni G, Menard S, Lollini PL.
    Int J Cancer; 2000 Jul 15; 87(2):186-94. PubMed ID: 10861472
    [Abstract] [Full Text] [Related]

  • 38. Effect of tyrphostin combined with a substance P related antagonist on small cell lung cancer cell growth in vitro.
    Seckl MJ, Rozengurt E.
    Eur J Cancer; 1996 Feb 15; 32A(2):342-5. PubMed ID: 8664052
    [Abstract] [Full Text] [Related]

  • 39. Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomes.
    Qian X, O'Rourke DM, Fei Z, Zhang HT, Kao CC, Greene MI.
    J Biol Chem; 1999 Jan 08; 274(2):574-83. PubMed ID: 9872991
    [Abstract] [Full Text] [Related]

  • 40. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.
    Gazit A, Osherov N, Posner I, Yaish P, Poradosu E, Gilon C, Levitzki A.
    J Med Chem; 1991 Jun 08; 34(6):1896-907. PubMed ID: 1676428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.